Awata N, Noumi K, Uemura Y, Takaki A, Aoyama T
Jpn J Antibiot. 1985 Jul;38(7):1776-84.
Metabolism of lenampicillin hydrochloride (LAPC), especially ampicillin (ABPC) structure of LAPC, was investigated after oral administration in human, dogs and rats. The unchanged compound was not detected in blood and urine, furthermore in animal portal vein after oral administration of LAPC in human and 2 animals. Therefore, LAPC seemed to be rapidly hydrolyzed during the process of absorption. The intestinal absorption of LAPC was satisfactory in view of the urinary excretion of metabolites, accounting for 93% of dose in human, 74% in dogs and 55% in rats, respectively. It could be judged by the bioautograms and the correlation between bioassay and HPLC determination of ABPC that the active metabolite in blood or urine was only ABPC. The major urinary metabolites were ABPC, alpha-aminobenzylpenicilloic acid (ABPA) and 5S-penicilloic acid isomer (5S-ABPA) in human and 2 animals, but the differences were observed on the excretion ratio between human, dogs and rats. LAPC was stable in the intestinal contents, but liable to hydrolyze in the intestinal wall, blood and liver of rats. From the facts described above, it was concluded that LAPC was the efficient prodrug of ABPC in terms of the enhancement of absorption and decrease of side effects.
研究了盐酸仑氨西林(LAPC)的代谢情况,尤其是其氨苄西林(ABPC)结构,在人体、犬和大鼠口服给药后进行了相关研究。在人体以及两种动物口服LAPC后,血液、尿液以及动物门静脉中均未检测到未变化的化合物。因此,LAPC在吸收过程中似乎迅速被水解。从代谢产物的尿排泄情况来看,LAPC的肠道吸收情况良好,在人体、犬和大鼠中分别占给药剂量的93%、74%和55%。通过生物自显影以及ABPC生物测定与高效液相色谱测定之间的相关性可以判断,血液或尿液中的活性代谢产物仅为ABPC。人体和两种动物的主要尿代谢产物为ABPC、α-氨基苄青霉素酸(ABPA)和5S-青霉素酸异构体(5S-ABPA),但在人体、犬和大鼠之间的排泄比例存在差异。LAPC在肠内容物中稳定,但在大鼠的肠壁、血液和肝脏中易于水解。基于上述事实,得出结论:就吸收增强和副作用减少而言,LAPC是ABPC的有效前药。